Nivolumab and bevacizumab attenuate cisplatin-induced hepatic inflammation and apoptosis in rats
{{output}}
Background and aim: Hepatotoxicity represents a significant adverse effect associated with cancer treatment. The present study was designed to evaluate the possible hepatoprotective effects of bevacizumab and nivolumab when admin... ...
